(Q52176677)

26 April 2018

title

NMDA receptors and behavioural sensitization: beyond dizocilpine. (English)

1 reference

26 April 2018

author name string

Wolf ME

series ordinal

1

1 reference

26 April 2018

publication date

1 May 1999

1 reference

26 April 2018

Trends in Pharmacological Sciences

published in

1 reference

26 April 2018

volume

20

1 reference

26 April 2018

issue

5

1 reference

26 April 2018

page(s)

188-9; author reply 189-90

1 reference

26 April 2018

Does the noncompetitive NMDA receptor antagonist dizocilpine (MK801) really block behavioural sensitization associated with repeated drug administration?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901356-5

7 January 2021

The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901356-5

7 January 2021

Can the "state-dependency" hypothesis explain prevention of amphetamine sensitization in rats by NMDA receptor antagonists?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901356-5

7 January 2021

MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901356-5

7 January 2021

MK-801 disrupts the expression but not the development of bromocriptine sensitization: a state-dependency interpretation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901356-5

7 January 2021

MK-801 (dizocilpine): synergist and conditioned stimulus in bromocriptine-induced psychomotor sensitization.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901356-5

7 January 2021

Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901356-5

7 January 2021

10.1016/S0165-6147(99)01356-5

Identifiers

DOI

1 reference

26 April 2018

1 reference

26 April 2018